ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
$8.55 USD
Updated Jul 19 12:00am
Add PRQR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
PRQR News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesProQR Therapeutics N.V. - Ordinary Shares (PRQR) Company Bio
ProQR Therapeutics is a biopharmaceutical company, focused on RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. The company was founded in 2012 and is based in Leiden, the Netherlands.
PRQR Stock Chart More Charts
PRQR Price/Volume Stats
| Current price | $8.55 |
| Prev. close | $8.59 |
| Day low | $8.30 |
| Day high | $8.83 |
| 50-day MA | $10.52 |
| 200-day MA | $14.57 |
| 52-week high | $24.00 |
| 52-week low | $6.40 |
| Volume | 264,700 |
| Avg. volume | 219,149 |
| Dividend yield | N/A |
| Market Cap | 332.36M |
PRQR Returns
| 1-mo | -14.59% |
| 3-mo | -24.60% |
| 6-mo | -45.16% |
| 1-year | 23.02% |
| 3-year | 78.87% |
| 5-year | N/A |
| YTD | -45.82% |
| 2018 | 389.30% |
| 2017 | -34.18% |
| 2016 | -43.55% |
| 2015 | -59.94% |
| 2014 | N/A |
Loading social stream, please wait...